Abiopharma

🔍 STIGALL L. JEREMY (Executive)

Company: ClearPoint Neuro, Inc. (CLPT)

Report Date: 2025-12-31

Detailed Transactions and Holdings:

• Acquired 1 shares of Common Stock at $9.57 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: false | shares_owned_after: 72,356.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.